{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:32:29Z","timestamp":1787671949436,"version":"build-2736575974"},"reference-count":32,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Regional citrate anticoagulation (RCA) is the preferred anticoagulation strategy for continuous kidney replacement therapy (CKRT) because it prolongs circuit lifespan while reducing bleeding complications compared with systemic heparin. Although generally safe, systemic citrate accumulation remains the principal metabolic complication of RCA and occurs when citrate delivery exceeds the combined metabolic and extracorporeal capacity for citrate elimination. This narrative review summarizes current evidence regarding citrate metabolism, the pathophysiological mechanisms of citrate accumulation, associated risk factors, biochemical diagnosis, monitoring strategies, and therapeutic management. Citrate metabolism depends predominantly on mitochondrial oxidative capacity rather than hepatic function alone, making circulatory shock and impaired tissue perfusion the principal determinants of citrate intolerance, whereas isolated liver dysfunction is often well tolerated. Systemic citrate accumulation is characterized by a distinctive biochemical profile including ionized hypocalcemia, an increased total-to-ionized calcium ratio, escalating calcium infusion requirements, high anion-gap metabolic acidosis, and frequently hyperlactatemia, while overt clinical manifestations usually occur late. Consequently, early recognition relies on structured biochemical monitoring and interpretation of serial trends rather than isolated measurements. Management should focus on restoring the balance between citrate delivery and citrate elimination by reducing citrate exposure when appropriate, optimizing extracorporeal citrate removal, correcting metabolic abnormalities, and improving tissue perfusion. Contemporary RCA practice should therefore emphasize individualized physiological assessment and integrated biochemical monitoring to facilitate early recognition, prevent progression to overt toxicity, and preserve the well-established safety and efficacy of RCA.<\/jats:p>","DOI":"10.3390\/jcm15176564","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:01:07Z","timestamp":1787670067000},"page":"6564","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Citrate Toxicity During Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-7574","authenticated-orcid":false,"given":"Sebastien","family":"Redant","sequence":"first","affiliation":[{"name":"Department of Intensive Care, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Place Van Gehuchtenplein 4, 1020 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Attou","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Place Van Gehuchtenplein 4, 1020 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea T.","family":"Talpos","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Brugmann University Hospital, Universit\u00e9 Libre de Bruxelles, Place Van Gehuchtenplein 4, 1020 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Honor\u00e9","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, CHU UCL Godinne Namur, UCLouvain Medical School, 5530 Yvoir, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","article-title":"Citrate vs heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study","volume":"30","author":"Monchi","year":"2004","journal-title":"Intensive Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","article-title":"Citrate versus heparin anticoagulation for continuous renal replacement therapy: An updated meta-analysis of randomized controlled trials","volume":"41","author":"Bai","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13054-023-04519-1","article-title":"Anticoagulation options for continuous renal replacement therapy in critically ill patients: A systematic review and network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou","year":"2023","journal-title":"Crit. Care"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jacobs, R., Verbrugghe, W., Dams, K., Roelant, E., Couttenye, M.M., Devroey, D., and Jorens, P. (2023). Regional citrate anticoagulation in continuous renal replacement therapy: Is metabolic fear the enemy of logic? A systematic review and meta-analysis of randomized controlled trials. Life, 13.","DOI":"10.3390\/life13051198"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1007\/s12325-025-03186-8","article-title":"Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment","volume":"42","author":"Rognoni","year":"2025","journal-title":"Adv. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s44158-023-00091-w","article-title":"Regional citrate anticoagulation in critically ill patients undergoing renal replacement therapy: Expert opinion from the SIAARTI-SIN joint commission","volume":"3","author":"Pistolesi","year":"2023","journal-title":"J. Anesth. Analg. Crit. Care"},{"key":"ref_8","first-page":"22","article-title":"Management of regional citrate anticoagulation for continuous renal replacement therapy: Guideline recommendations from Chinese emergency medical doctor consensus","volume":"10","author":"Liu","year":"2023","journal-title":"Mil. Med. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/cc11645","article-title":"Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice","volume":"16","author":"Ostermann","year":"2012","journal-title":"Crit. Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","article-title":"Complications of regional citrate anticoagulation: Accumulation or overload?","volume":"21","author":"Schneider","year":"2017","journal-title":"Crit. Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","article-title":"Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation","volume":"29","author":"Khadzhynov","year":"2014","journal-title":"J. Crit. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MNH.0000000000000953","article-title":"Let\u2019s stop talking about \u201ccitrate toxicity\u201d","volume":"33","author":"Israni","year":"2024","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_13","first-page":"1247","article-title":"The role of mitochondrial dysfunction in sepsis-induced multi-organ failure","volume":"94","author":"Singer","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","article-title":"Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients","volume":"31","author":"Kramer","year":"2003","journal-title":"Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.ajkd.2006.07.016","article-title":"Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration","volume":"48","author":"Hetzel","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/clinchem\/31.2.244","article-title":"Relationships between magnesium and protein concentrations in serum","volume":"31","author":"Kroll","year":"1985","journal-title":"Clin. Chem."},{"key":"ref_17","first-page":"202","article-title":"Clinical review: Anticoagulation for continuous renal replacement therapy-heparin or citrate?","volume":"15","author":"Kellum","year":"2011","journal-title":"Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"c131","DOI":"10.1159\/000079171","article-title":"Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience","volume":"97","author":"Morgera","year":"2004","journal-title":"Nephron Clin. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcrc.2020.06.009","article-title":"Total-to-ionized calcium ratio, taken alone, is no longer valid to diagnose citrate accumulation","volume":"59","year":"2020","journal-title":"J. Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","article-title":"Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation","volume":"29","author":"Gitomer","year":"2001","journal-title":"Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1523-1755.2001.00809.x","article-title":"Simplified citrate anticoagulation for continuous renal replacement therapy","volume":"60","author":"Tolwani","year":"2001","journal-title":"Kidney Int."},{"key":"ref_22","first-page":"439","article-title":"Citrate anticoagulation for CRRT in patients with acute kidney injury admitted to the ICU","volume":"2","author":"Davenport","year":"2009","journal-title":"NDT Plus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/ndt\/gfad068","article-title":"Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance","volume":"38","author":"Sabatino","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s13054-026-06066-x","article-title":"Metabolic complications of citrate anticoagulation in continuous renal replacement therapy (CRRT): A Delphi consensus on indications, monitoring and management","volume":"30","author":"Jacobs","year":"2026","journal-title":"Crit. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41598-022-05867-8","article-title":"Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT","volume":"12","author":"Thanapongsatorn","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-021-03819-8","article-title":"Association between longer duration of citrate accumulation and 90-day mortality of acute-on-chronic liver failure","volume":"25","author":"Wang","year":"2021","journal-title":"Crit. Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13054-025-05648-5","article-title":"Clinical and biological profiles associated with the time of occurrence of citrate accumulation in patients receiving continuous renal replacement therapy","volume":"29","author":"Bidar","year":"2025","journal-title":"Crit. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"25071","DOI":"10.1074\/jbc.272.40.25071","article-title":"Nitric oxide and aconitase inhibition","volume":"272","author":"Gardner","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/cc11403","article-title":"Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding","volume":"16","author":"Morabito","year":"2012","journal-title":"Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc11363","article-title":"Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients","volume":"16","author":"Link","year":"2012","journal-title":"Crit. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0272-6386(96)90162-6","article-title":"Regional hemodialysis anticoagulation: Hypertonic trisodium citrate or anticoagulant citrate dextrose-A","volume":"27","author":"Flanigan","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"ref_32","first-page":"205","article-title":"Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation","volume":"6","author":"Brain","year":"2004","journal-title":"Crit. Care Resusc."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6564\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:10:35Z","timestamp":1787670635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":32,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176564"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176564","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}